| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI109113 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC371736 |
| https://europepmc.org/articles/PMC371736?pdf=render | ||
| P932 | PMC publication ID | 371736 |
| P698 | PubMed publication ID | 659637 |
| P2093 | author name string | H. Saito | |
| Goldsmith GH Jr | |||
| G. H. Goldsmith | |||
| O. S. Ratnoff | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin | Q33366163 | ||
| Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation | Q34462395 | ||
| Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil | Q34478766 | ||
| An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH | Q35194006 | ||
| The Hageman Factor Dependent Pathways of Coagulation, Fibrinolysis, and Kinin-Generation | Q35375867 | ||
| Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors | Q35573276 | ||
| The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator | Q36272174 | ||
| Occurrence of Cl Inactivator and Other Proteinase Inhibitors in Euglobulin Fractions and Their Influence on Fibrinolytic Activity | Q39126709 | ||
| Structural changes accompanying enzymatic activation of human Hageman factor | Q40368436 | ||
| Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI). | Q44690742 | ||
| Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease in various animal plasmas | Q47334749 | ||
| Defective Activation of Clotting, Fibrinolytic, and Permeability-Enhancing Systems in Human Fletcher Trait Plasma | Q47872311 | ||
| Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum. | Q53735624 | ||
| Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma. | Q54398082 | ||
| Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay | Q67598652 | ||
| Activation of plasminogen by human plasma kallikrein | Q68435579 | ||
| Plasminogen: Purification from Human Plasma by Affinity Chromatography | Q71582386 | ||
| PURIFICATION OF ACTIVATED BOVINE HAGEMAN FACTOR | Q76599990 | ||
| Role of the contact factor (Hageman factor) in fibrinolysis | Q78847262 | ||
| The purification of activated Hageman factor (activated factor XII) | Q79601728 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasminogen activator | Q13581432 |
| plasminogen | Q107129060 | ||
| P304 | page(s) | 54-60 | |
| P577 | publication date | 1978-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments | |
| P478 | volume | 62 |
| Q70260301 | A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogen |
| Q35321833 | Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli |
| Q47911391 | Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development |
| Q36337574 | Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination |
| Q28072738 | Bradykinin: Inflammatory Product of the Coagulation System |
| Q31132259 | C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage |
| Q40684870 | C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. |
| Q34534792 | Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients |
| Q69011971 | Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass |
| Q38020323 | FXII. |
| Q36037758 | Formation of bradykinin: a major contributor to the innate inflammatory response |
| Q39301841 | Global assays of fibrinolysis. |
| Q34741422 | Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema |
| Q35208694 | Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor |
| Q37346121 | Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII) |
| Q72711939 | Induction of proteolytic activity in serum by treatment with anionic detergents and organic solvents |
| Q33232415 | One-step preparation of Hageman factor fragment concentrate |
| Q40603689 | Physiology of hemostasis. |
| Q39330912 | Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity |
| Q40342286 | Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo |
| Q34608959 | Surface-mediated defense reactions. The plasma contact activation system |
| Q40104724 | The Biochemistry and Pathophysiology of the Contact System of Plasma |
| Q39780188 | The contact activation system: biochemistry and interactions of these surface-mediated defense reactions |
| Q40076028 | The fibrinolytic system in man |
| Q41118917 | The influence of biomaterials on inflammatory responses to cardiopulmonary bypass |
| Q35148421 | The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction |
Search more.